TORONTO, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough ventures that transform human wellness, is pleased to announce that its U.S. biosciences subsidiary Mikra Cellular Sciences Inc. ("Mikra") has joined with U.S. based AcousticSheep LLC (“AcousticSheep”) to offer a SleepPhones® x Serenity Giveaway. Enter as many times as you wish to win a free pair of SleepPhones® and a three month supply of Serenity per the contest rules at https://tinyurl.com/28j7nfw7.
“We are delighted to partner with Mikra for this SleepPhones® x Serenity giveaway,” said Andrew Dalton, Director of Sales & Marketing at AcousticSheep, the makers of SleepPhones®. “SleepPhones® headphones and Serenity have natural synergy, which was heavily reflected in the success of the collaboration.”
“It has been a pleasure working with AcousticSheep on this giveaway,” said Andrea Judge, CEO of Mikra. “We appreciate their customer-focused business model and the quality of their SleepPhones®. The collaboration was a natural fit, and we look forward to announcing more product collaborations and giveaways in the near future.”
Serenity has been formulated based on steam extract of lavender oil, combined with Mikra’s proprietary polyterpene blend of passionflower, chamomile and lemon balm. Lavender oil extract has undergone thorough evaluation in randomized, double-blind clinical trials, where it demonstrated notable effectiveness even surpassing that of paroxetine (PaxilTM), a leading SSRI recommended for managing generalized anxiety disorder1. This study's findings indicated that lavender oil extract is both efficacious and well-tolerated in patients with generalized anxiety disorder (GAD), enabling termination after a 10-week treatment at the full therapeutic dose without down-titration and without inducing withdrawal symptoms.
In Europe, lavender oil extract has gained prominence as a primary, first-line strategy in addressing anxiety-related concerns and has secured widespread approval for this purpose.2
What sets Serenity apart is the GCMS-verified precision of the active ingredient dosage, and the incorporation of Mikra's proprietary polyterpene blend, meticulously crafted to deliver a pleasing flavor profile and address the common concern raised by initial users of other oral lavender products regarding their "perfume-like" taste and aftertaste. Capitalizing on our team’s experience with fragrant and flavorful botanicals, Serenity is poised to be among the most palatable lavender oil extract supplements on the market, with the most consistent, reliably precise dose every time.
Lifeist is committed to bringing natural products backed by real science to market and looks forward to reaching many more customers in new and innovative ways in 2024 and beyond.
About AcousticSheep® LLC
AcousticSheep LLC was founded by Dr. Wei-Shin Lai and Jason Wolfe in 2007. Wei-Shin Lai, a family physician, could not get back to sleep after taking patient calls at night. Her husband, Jason Wolfe suggested she listen to relaxing sleep sounds in order to fall back asleep, but regular headphones and earbuds were uncomfortable. To solve this problem, they decided to make the first headphones designed specifically for sleeping. He soldered and she sewed the first “headphones in a headband” at their kitchen table and called them SleepPhones® headphones.
More than a million SleepPhones® headphones have been sold to date, and Jason and Wei-Shin have earned recognition such as Entrepreneur of the Year in PA (SBA), Entrepreneur of the Year in Western PA & WV (Ernst & Young), EXIM Bank Exporter of the Year, and Small Business of the Year with the Consumer Technology Association. Their products have won eight Consumer Electronics Association Innovation Awards, two Pennsylvania ImPAct Awards (Entrepreneur and Exports), and a Red Dot Design Award. For more information about the company visit www.AcousticSheep.com.
About Lifeist Wellness Inc.
Sitting at the forefront of the post-pandemic wellness revolution, Lifeist leverages advancements in science and technology to build breakthrough companies that transform human wellness. Portfolio business units include: Mikra, a biosciences and consumer wellness company developing and selling innovative products for cellular health; and CannMart, which operates a B2B wholesale distribution business facilitating recreational cannabis sales to Canadian provincial government control boards including for CannMart Labs, a BHO extraction facility producing high margin cannabis 2.0 products.
Information on Lifeist and its businesses can be accessed through the links below:
www.lifeist.com
https://wearemikra.com/
https://cannmart.com
Contact:
Meni Morim
CEO
Lifeist Wellness Inc.
Ph: 647-362-0390
Email: ir@lifeist.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release.
Forward Looking Information
This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not historical in nature contain forward-looking information. Forward-looking information can be identified by words or phrases such as “may”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen.
The forward-looking information contained herein, including, without limitation, statements related to the new marketing campaigns for Serenity, CELLF and Rescue and the anticipated benefits of using Serenity, as a natural alternative, instead of antidepressants to treat anxiety are made as of the date of this news release and are based on assumptions management believed to be reasonable at the time such statements were made, including without limitation, that new marketing campaigns that effectively demonstrate the benefits of Mikra’s products will be developed in a timely manner and on budget, Mikra will be able to continue to deliver orders for Serenity, expectations relating to the effectiveness of lavender oil and its extracts in treating anxiety as demonstrated in published materials and studies, its expectation that the nutraceutical market will develop as currently anticipated, the nutraceutical market will continue to be a multi-billion dollar high-margin market, expectations that Serenity will gain market acceptance as a natural supplement alternative for the treatment of anxiety, along with the expansion of the market for nutraceutical products, as well as other considerations that are believed to be appropriate in the circumstances. While we consider these assumptions to be reasonable based on information currently available to management, there is no assurance that such expectations will prove to be correct. By its nature, forward-looking information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct, and that objectives, strategic goals and priorities will not be achieved. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this news release. Such factors include, without limitation: the Company’s inability to develop successful marketing campaigns for its products, the failure to continue to receive and fulfill orders for Serenity and its other products, the failure of Serenity, a natural supplement alternative, to demonstrate a notable effectiveness in treating general anxiety disorder or other anticipated health benefits, the inability of the Company to develop Mikra’s business as anticipated, unanticipated changes to current regulations that would adversely impact Mikra’s business, unforeseen developments that would delay Mikra’s ability to continue to sell Serenity, the risk that the expected demand for nutraceutical products in general and those of Mikra in particular does not develop as anticipated and risks relating to the Company’s ability to execute its business strategy and the benefits realizable therefrom. Additional risk factors can also be found in the Company’s current MD&A filed under the Company’s SEDAR profile at www.sedarplus.ca. Readers are cautioned not to put undue reliance on forward-looking information. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable law. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.
Source: Lifeist Wellness Inc.
1 Lavender oil preparation is effective in generalized anxiety disorder - https://pubmed.ncbi.nlm.nih.gov/24456909/
2 Lavandulae aetheroleum - https://www.ema.europa.eu/en/medicines/herbal/lavandulae-aetheroleum
TM All referenced trademarks are the property of their respective owners.
